Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States
- PMID: 28978103
- PMCID: PMC5620243
- DOI: 10.18632/oncotarget.19245
Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States
Abstract
Background: Hepatocellular carcinoma possesses a notable sex difference in incidence, and a protective role of estrogens has been hypothesized.
Methods: Using data from 13 cancer registries in the Surveillance, Epidemiology, and End Results Program, we describe the age-specific sex difference in the incidence of hepatocellular carcinoma in the United States during 1992-2013. We used a curve fitting by non-linear regression to quantitatively characterize the age-specific incidence rate of hepatocellular carcinoma by sex.
Results: A total of 44,287 incident cases of hepatocellular carcinoma (33,196 males and 11,091 females) were included, with an overall male-to-female ratio in age-standardized rate of 3.55. The sex ratio was below 2 at ages <25 years, increased with age from ages 25-29 years until peaking at 5.40 at ages 50-54 years, and declined thereafter. We also observed additional peaks in the age-specific sex ratio curves at ages 25-34 years across racial/ethnic groups. Modelling of age-specific incidence rates indicated a 15-year delayed increase with age in females compared with males in Asian and Pacific Islanders, and an 11-year delay in Hispanic whites.
Conclusions: The age-dependent patterns in the sex difference in the incidence of hepatocellular carcinoma support the hypothesis of a protective role of estrogens. The underlying reasons for the sex difference in hepatocellular carcinoma remain to be further explored in analytic epidemiological studies.
Keywords: estrogen; hepatocellular carcinoma; incidence; liver cancer; sex difference.
Conflict of interest statement
CONFLICTS OF INTEREST The authors declare no conflicts of interest.
Figures



Similar articles
-
Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983-2008: suggestion of a potential protective role of oestrogen.Eur J Cancer. 2013 Jan;49(1):150-5. doi: 10.1016/j.ejca.2012.07.004. Epub 2012 Aug 11. Eur J Cancer. 2013. PMID: 22892061
-
Epidemiology of hepatocellular carcinoma in Hispanics in the United States.Arch Intern Med. 2007 Oct 8;167(18):1983-9. doi: 10.1001/archinte.167.18.1983. Arch Intern Med. 2007. PMID: 17923599
-
Sex difference in the incidence of cardia and non-cardia gastric cancer in the United States, 1992-2014.BMC Gastroenterol. 2020 Dec 11;20(1):418. doi: 10.1186/s12876-020-01551-1. BMC Gastroenterol. 2020. PMID: 33308167 Free PMC article.
-
Toxicology and carcinogenesis studies of androstenedione (CAS No. 63-05-8) in F344/N rats and B6C3F1 mice (gavage studies).Natl Toxicol Program Tech Rep Ser. 2010 Sep;(560):1, 7-31,33-171 passim. Natl Toxicol Program Tech Rep Ser. 2010. PMID: 21037592 Review.
-
[Epidemiology of hepatocellular carcinoma in the department of Calvados].Gastroenterol Clin Biol. 1997;21(6-7):450-8. Gastroenterol Clin Biol. 1997. PMID: 9295971 Review. French.
Cited by
-
Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.Radiol Imaging Cancer. 2024 Jan;6(1):e230118. doi: 10.1148/rycan.230118. Radiol Imaging Cancer. 2024. PMID: 38214600 Free PMC article.
-
Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival.Epigenetics. 2020 Dec;15(12):1302-1318. doi: 10.1080/15592294.2020.1770917. Epub 2020 Jun 1. Epigenetics. 2020. PMID: 32476555 Free PMC article.
-
The Incidence Rate of Liver Cancer in Saudi Arabia: An Observational Descriptive Epidemiological Analysis of Data from the Saudi Cancer Registry (2004-2014).Cancer Manag Res. 2020 Feb 13;12:1101-1111. doi: 10.2147/CMAR.S232600. eCollection 2020. Cancer Manag Res. 2020. PMID: 32104090 Free PMC article.
-
The Potential Inhibitory Role of Acetyl-L-Carnitine on Proliferation, Migration, and Gene Expression in HepG2 and HT29 Human Adenocarcinoma Cell Lines.Curr Issues Mol Biol. 2023 Mar 14;45(3):2393-2408. doi: 10.3390/cimb45030155. Curr Issues Mol Biol. 2023. PMID: 36975525 Free PMC article.
-
Prognostic predictive value of the preoperative systemic immunoinflammatory index combined with the neutrophil-to-lymphocyte ratio in patients with primary liver cancer undergoing transarterial chemoembolization.Oncol Lett. 2025 Jun 27;30(3):414. doi: 10.3892/ol.2025.15160. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40630711 Free PMC article.
References
-
- El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27. - PubMed
-
- Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357:1974–6. - PubMed
-
- El Mahdy Korah T, Abd Elfatah Badr E, Mohamed Emara M, Ahmed Samy Kohla M, Gamal Saad Michael G. Relation between sex hormones and hepatocellular carcinoma. Andrologia. 2016;48:948–55. - PubMed
-
- Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010;78(Suppl 1):172–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical